WHO ICTRP trial
Minoxidil 5 mg oral versus Minoxidil 5% topical solution for Male Pattern…
RBR-252w9r · Registro Brasileiro de Ensaios Clinicos (ReBEC) · Not Recruiting
Key facts
| Trial ID | RBR-252w9r |
|---|---|
| Public title | Minoxidil 5 mg oral versus Minoxidil 5% topical solution for Male Pattern Baldness: randomized clinical trial |
| Scientific title | Minoxidil 5 mg oral versus Minoxidil 5% topical solution for Treatment of Male Androgenetic Alopecia: Randomized Clinical Trial |
| Primary sponsor | Universidade Estadual Paulista Julio de Mesquita Filho |
| Secondary sponsors | Universidade Estadual Paulista Julio de Mesquita Filho |
| Registry | Registro Brasileiro de Ensaios Clinicos (ReBEC) |
| Recruitment status | Not Recruiting |
| Study type | Intervention |
| Countries | Brazil |
| Conditions | male androgenetic alopecia;C17.800.329.937.122;L64.9 |
| Interventions | After signing the consent form, patients will be randomized (1: 1) into two groups: oral minoxidil 5 mg daily (Loniten® tablet fractionated in capsule 5mg) and placebo topical solution for use 2x daily. ; minoxidil 5% solution (Pant®) 1ml… |
| Registration date | Sep 2, 2020 |
| Registry page | ensaiosclinicos.gov.br |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: